天美传媒

ISSN: 2167-065X

Clinical Pharmacology & Biopharmaceutics
天美传媒 Access

Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ 天美传媒 Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

天美传媒 Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Citations : 1089

Indexed In
  • CAS Source Index (CASSI)
  • Index Copernicus
  • Google Scholar
  • Sherpa Romeo
  • Genamics JournalSeek
  • RefSeek
  • Hamdard University
  • EBSCO A-Z
  • OCLC- WorldCat
  • Publons
  • Euro Pub
  • ICMJE
Share This Page

The novel slow-releasing hydrogen sulfide (H2S) donor P* induces apoptotic cell death in Jurkat leukemia T cells

7th Annual Global Pharma Summit

Burkhard Kloesch

Ludwig Boltzmann Cluster for Arthritis and Rehabilitation, Austria

Posters & Accepted Abstracts: Clin Pharmacol Biopharm

DOI:

Abstract
Background & Aim: Numerous studies have reported about the different role of H2S in cell survival, proliferation and apoptosis in human cancer cell lines. In the present work, we investigated the anti-proliferative and pro-apoptotic potential of substance P* in Jurkat leukemia T cells. P* is a persulfide analog of the nitrosothiol S-nitroso-N-acetyl-D,L-penicillamine (SNAP) which releases H2S only in the presence of thiols (reduced glutathione or L-cysteine). Materials & Methods: Proliferation and cell viability of Jurkat T cells were determined with 2,3-bis-(2-methoxy-4-nitro-5- sulfophenyl)-2H-tetrazolium-5-carboxanilide assay, Annexin-V/7-AAD staining and Western blot. To induce cytokine production, the cells were stimulated with phorbol 12-myristate 13-acetate plus A23187 with or without different concentrations of P*. The release of interleukin (IL-) 2 was quantified by enzyme-linked immunosorbent assay. Results: Substance P* reduced proliferation and cell viability of Jurkat T cells in a dose-dependent manner. P* induced cleavage of pro-caspase-3/-7, poly (ADP-ribose) polymerase, myeloid cell leukemia-1 and ?虏-catenin. The addition of high concentrations of antioxidants such as N-acetyl-cysteine or L-cysteine could completely prevent apoptotic cell death of Jurkat T cells. In strong contrast to P*, the 芒??classic芒?聺 H2S donor sodium hydrogen sulfide (NaHS) did not affect cell viability. Besides the pro-apoptotic activities of P*, it also blocked IL-2 synthesis. Conclusion: The slow-releasing and thiol-inducible H2S donor P* showed potent antiproliferative and pro-apoptotic activities in Jurkat leukemia T cells. We suggest that treatment of Jurkat T cells with P* may lead to an imbalance in the redox system (GSH depletion?) which in turn induces the apoptotic (caspase-3) signaling pathway.
Biography

Email: burkhard.kloesch@gmx.at

International Conferences 2025-26
 
Meet Inspiring Speakers and Experts at our 3000+ Global

Conferences by Country

Medical & Clinical Conferences

Conferences By Subject

Top